Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2017 Earnings

7NovConfirmed

Q1 2017

Q2 2017

Q3 2017

Q4 2017

-4.38

-4.14

-3.9

-3.66

Details

Expected EPS

-4.152519

Actual EPS

-4.381398

Surprise EPS

-0.23

Surprise Percent

+5.51%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -4.381398 per share for Q4 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.